Status:
COMPLETED
Enhanced Recovery After Surgery for SPK Transplantation Recipients
Lead Sponsor:
Second Affiliated Hospital of Guangzhou Medical University
Conditions:
Transplant Complication
Diabetic Nephropathy
Eligibility:
All Genders
20-62 years
Phase:
NA
Brief Summary
108 patients underwent elective SPK surgery were randomly divided into ERAS group (E) and routine care group (T). The ERAS group was consisted of evidenced-based systematic optimization approaches, wh...
Detailed Description
Primary results: the postoperative length of stay (LoS) and hospitalization costs; second results: post-operative analgesia score (NRS) , the incidence of post-operative nausea and vomiting (PONV) , u...
Eligibility Criteria
Inclusion
- Patients were aged 20-62 years
- Body mass index (BMI) of 18.5-32.9 kg/m2
- Voluntary participation for elective SPK surgery
- ERSD and DN patients waiting for SPK transplantation surgery.
Exclusion
- History of allergy to narcotic drugs
- cardiopulmonary insufficiency
- congestive heart failure
- myasthenia gravis
- neurological disease
- mental illness
- severe liver dysfunction
- hyperkalaemia
- malignant hyperthermia
- unwilling to participate in the study for any reason, or had participated in another study within the 3 months
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2023
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06095544
Start Date
January 1 2021
End Date
June 1 2023
Last Update
October 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Second affiliated hospital of Guangzhou Medical University
Guangzhou, Guangdong, China, 510260